TrialEuropean heart journal2022

Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.

Wolfram Doehner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.